Tristel plc (AIM: TSTL)

Market Cap	188.38M
Revenue (ttm)	41.93M
Net Income (ttm)	6.49M
Shares Out	47.69M
EPS (ttm)	0.14
PE Ratio	29.17
Forward PE	24.99
Dividend	0.14 (3.42%)
Ex-Dividend Date	Nov 28, 2024

Volume	17,803
Average Volume	44,018
Open	400.62
Previous Close	404.00
Day's Range	390.00 - 405.00
52-Week Range	346.00 - 510.00
Beta	0.18
RSI	43.74
Earnings Date	Feb 24, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.